{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T07:39:42Z","timestamp":1782545982379,"version":"3.54.5"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Perivascular epithelioid cell tumors (PEComas) are rare, typically benign soft tissue tumors that can develop at various anatomic sites. Malignant PEComas are rarer entities but may present aggressively with metastasis to the lungs or local recurrence years after initial presentation. In unresectable or metastatic cases, treatment options are limited due to the resistance of PEComas to chemotherapy and radiotherapy. The present case describes a 59-year-old man with a highly aggressive malignant PEComa, which ultimately invaded the mediastinum and replaced the right middle and lower lobes of the lung despite systemic therapy with oral sirolimus and definitive radiotherapy. As only three prior cases have described malignant PEComas invading the mediastinum, we highlight the clinical course of such an aggressive cancer and review current treatment paradigms.<\/jats:p>","DOI":"10.3389\/fonc.2025.1551663","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:29:00Z","timestamp":1755494940000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Malignant perivascular epithelioid cell tumor with aggressive mediastinal invasion and pulmonary metastasis"],"prefix":"10.3389","volume":"15","author":[{"suffix":"III","given":"Daniel F.","family":"Leach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srivikram","family":"Margam S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrod B.","family":"Adkison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2015.06.003","article-title":"PEComa: morphology and genetics of a complex tumor family","volume":"19","author":"Thway","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00292-019-0612-5","article-title":"Complexity of PEComas: Diagnostic approach, molecular background, clinical management","volume":"41","author":"Utpatel","year":"2020","journal-title":"Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0509-1","article-title":"PEComas: the past, the present and the future","volume":"452","author":"Martignoni","year":"2008","journal-title":"Virchows Arch Int J Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.3390\/cancers13205227","article-title":"Natural history and treatment strategies of advanced PEComas: A systematic review","volume":"13","author":"Bourgmayer","year":"2021","journal-title":"Cancers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05114-1","article-title":"Perivascular epithelioid cell tumors (PEComas) of the bone and soft tissue: a Japanese Musculoskeletal Oncology Group (JMOG) multi-institutional study","volume":"149","author":"Izubuchi","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijsu.2015.05.002","article-title":"Perivascular epithelioid cell neoplasm (PEComa) of the uterus: A systematic review","volume":"19","author":"Musella","year":"2015","journal-title":"Int J Surg Lond Engl"},{"key":"B7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40644-019-0212-x","article-title":"Primary hepatic perivascular epithelioid cell tumors: imaging findings with histopathological correlation","volume":"19","author":"Nie","year":"2019","journal-title":"Cancer Imag"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2015.02.006","article-title":"PEComas of the kidney and of the genitourinary tract","volume":"32","author":"Martignoni","year":"2015","journal-title":"Semin Diagn Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5114\/pjp.2017.67623","article-title":"Perirenal perivascular epithelioid cell tumor (PEComa) coexisting with other Malignancies: a case report","volume":"68","author":"Danilewicz","year":"2017","journal-title":"Pol J Pathol Off J Pol Soc Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i4.1349","article-title":"Coincidence between Malignant perivascular epithelioid cell tumor arising in the gastric serosa and lung adenocarcinoma","volume":"21","author":"Yamada","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e250466","DOI":"10.1136\/bcr-2022-250466","article-title":"Primary retroperitoneal PEComa: an incidental finding","volume":"15","author":"Marinho","year":"2022","journal-title":"BMJ Case Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2022.11.042","article-title":"Malignant retroperitoneal PEComa: A case report with emphasis on radiological findings","volume":"18","author":"Dhaliwal","year":"2023","journal-title":"Radiol Case Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2016.04.20","article-title":"A case of Malignant PEComa of the uterus associated with intramural leiomyoma and endometrial carcinoma","volume":"50","author":"Choi","year":"2016","journal-title":"J Pathol Transl Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2016.02.004","article-title":"Malignant perivascular epithelioid cell neoplasm (PEComa) of the pelvis: A case report","volume":"6","author":"D\u2019Andrea","year":"2016","journal-title":"Urol Case Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102200","article-title":"Feasibility and long-term efficacy of PEComa treatment\u201420 years of experience","volume":"10","author":"Sobiborowicz","year":"2021","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-011-0268-9","article-title":"Perivascular epithelioid cell tumors (PEComas) of the head and neck: report of three cases and review of the literature","volume":"5","author":"Bandhlish","year":"2011","journal-title":"Head Neck Pathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e29246","DOI":"10.7759\/cureus.29246","article-title":"Perivascular epithelioid cell tumor (PEComa) of the lung in a 56-year-old female patient: A case report","volume":"14","author":"Donato","year":"2022","journal-title":"Cureus"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5090\/jcs.22.139","article-title":"Primary perivascular epithelioid cell tumor of the lung: A case report","volume":"56","author":"Na","year":"2023","journal-title":"J Chest Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12885-019-5383-0","article-title":"Malignant perivascular epithelioid cell tumor of the lung synchronous with a primary adenocarcinoma: one case report and review of the literature","volume":"19","author":"Zhao","year":"2019","journal-title":"BMC Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2018.02.007","article-title":"Primary pancreatic perivascular epithelioid cell tumor (PEComa): A surgical enigma. A systematic review of the literature","volume":"18","author":"Zizzo","year":"2018","journal-title":"Pancreatol Off J Int Assoc Pancreatol IAP Al"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.0746","article-title":"A resected perivascular epithelioid cell tumor (PEComa) of the pancreas diagnosed using endoscopic ultrasound-guided fine-needle aspiration","volume":"52","author":"Okuwaki","year":"2013","journal-title":"Intern Med Tokyo Jpn"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1350123","article-title":"Primary perivascular epitheloid cell tumour (PEComa) of the liver: case report and review of the literature","volume":"51","author":"Jafari","year":"2013","journal-title":"Z Gastroenterol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-023-01779-w","article-title":"Hepatic perivascular epithelioid cell tumor (PEComa): contrast-enhanced ultrasound (CEUS) characteristics-a case report and literature review","volume":"16","author":"Matrood","year":"2023","journal-title":"Clin J Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181854929","article-title":"Perivascular epithelioid cell tumor (PEComa) of the urinary bladder: report of 3 cases and review of the literature","volume":"33","author":"Sukov","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2011.11.002","article-title":"Malignant PEComa of the adrenal gland","volume":"208","author":"Lau","year":"2012","journal-title":"Pathol Res Pract"},{"key":"B26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1746-1596-7-23","article-title":"Multifocal PEComa (PEComatosis) of the female genital tract and pelvis: a case report and review of the literature","volume":"7","author":"Yang","year":"2012","journal-title":"Diagn Pathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12972","article-title":"Primary cutaneous perivascular epithelioid cell tumor (PEComa): Five new cases and review of the literature","volume":"44","author":"Stuart","year":"2017","journal-title":"J Cutan Pathol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13000-015-0292-2","article-title":"Malignant perivascular epithelioid cell tumor (PEComa) of the femur: a case report and literature review","volume":"10","author":"Lao","year":"2015","journal-title":"Diagn Pathol"},{"key":"B29","article-title":"Histopathologic characteristics and immunotypes of perivascular epithelioid cell tumors (PEComa)","volume":"12","author":"Bao","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives","volume":"113","author":"Sbaraglia","year":"2021","journal-title":"Pathologica"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5131736","DOI":"10.1155\/2020\/5131736","article-title":"A primary adrenal epithelioid angiomyolipoma (PEComa) in a patient with tuberous sclerosis complex: report of a case and review of the literature","volume":"2020","author":"Torres Luna","year":"2020","journal-title":"Case Rep Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001024","article-title":"Fibroma-like PEComa: A tuberous sclerosis complex-related lesion","volume":"42","author":"Larque","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000173232.22117.37","article-title":"Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature","volume":"29","author":"Folpe","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"541626","DOI":"10.1155\/2012\/541626","article-title":"Malignant\u201d Perivascular epithelioid cell neoplasm: risk stratification and treatment strategies","volume":"2012","author":"Bleeker","year":"2012","journal-title":"Pollock R Editor Sarcoma"},{"key":"B35","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.jbo.2020.100336","article-title":"Primary perivascular epithelioid cell tumor (PEComa) in bone: A review of the literature and a case arising in the humerus with multiple metastases","volume":"26","author":"Zhong","year":"2021","journal-title":"J Bone Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s40792-021-01314-4","article-title":"A successful case of complete surgical resection via left upper and right lower lobectomy for bilateral lung metastases of a perivascular epithelioid cell tumor in the colon: a case report","volume":"7","author":"Fuse","year":"2021","journal-title":"Surg Case Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-762","article-title":"Extremely late-onset pulmonary metastasis from uterine PEComa","volume":"114","author":"Ascione","year":"2022","journal-title":"Pathologica"},{"key":"B38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5603\/OCP.2020.0003","article-title":"Diagnosis and treatment of Malignant PEComa tumours","volume":"16","author":"Sobiborowicz","year":"2020","journal-title":"Oncol Clin Pract"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrpr.2017.04.001","article-title":"Huge soft tissue PEComa with aggressive lung and bone metastases","volume":"4","author":"Tang","year":"2017","journal-title":"J Cancer Res Pract"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200412000-00017","article-title":"Malignant perivascular epithelioid\u00a0cell tumour (\u201cPEComa\u201d) of soft tissue: a unique case","volume":"28","author":"Harris","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.rmcr.2017.06.011","article-title":"Pneumothorax caused by cystic and nodular lung metastases from a Malignant uterine perivascular epithelioid cell tumor (PEComa)","volume":"22","author":"Okamoto","year":"2017","journal-title":"Respir Med Case Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"29:300658","DOI":"10.1016\/j.hpr.2022.300658","article-title":"Perivascular epithelioid cell tumor in the mediastinum: Metastasis or multiple primaries","author":"Kinskey","year":"2022","journal-title":"Hum Pathol Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e904","DOI":"10.1097\/MD.0000000000000904","article-title":"Malignant perivascular epithelioid cell neoplasm of the mediastinum and the lung: one case report","volume":"94","author":"Liang","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"20220105","DOI":"10.1259\/bjrcr.20220105","article-title":"Renal and mediastinal perivascular epithelioid cell tumors (PEComas) in a young child with tuberous sclerosis; a rare case report","volume":"9","author":"Attia","year":"2022","journal-title":"BJR Case Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.01.008","article-title":"Comparative genomic hybridization study of perivascular epithelioid cell tumor: molecular genetic evidence of perivascular epithelioid cell tumor as a distinctive neoplasm","volume":"37","author":"Pan","year":"2006","journal-title":"Hum Pathol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.582087\/full","article-title":"Case report: gastrointestinal PEComa with TFE3 rearrangement treated with anti-VEGFR TKI apatinib","volume":"10","author":"Xu","year":"2020","journal-title":"Front Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.966818\/full","article-title":"Case report: Kidney perivascular epithelioid cell tumor treated with anti-VEGFR tyrosine kinase inhibitor and MTOR inhibitor","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-23-0139","article-title":"Systemic treatments and molecular biomarkers for perivascular epithelioid cell tumors: A single-institution retrospective analysis","volume":"3","author":"Testa","year":"2023","journal-title":"Cancer Res Commun"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2024.06.007","article-title":"Uterine perivascular epithelioid cell tumors (PEComa) and the accuracy of proposed classification systems in predicting the Malignant versus non-malignant behavior","author":"Garzon","year":"2024","journal-title":"Gynecol Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35277","article-title":"PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent","volume":"130","author":"Gantzer","year":"2024","journal-title":"Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1510\/icvts.2007.154039","article-title":"Pecoma of the lung: a benign tumor with extensive 18F-2-deoxy-D-glucose uptake","volume":"6","author":"Zarbis","year":"2007","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.13.10909","article-title":"Imaging features of primary and metastatic Malignant perivascular epithelioid cell tumors","volume":"202","author":"Tirumani","year":"2014","journal-title":"Am J Roentgenol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13000-023-01323-x","article-title":"A rare metastatic mesenteric Malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report","volume":"18","author":"Meredith","year":"2023","journal-title":"Diagn Pathol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.11005","article-title":"ABI-009 (nab-sirolimus) in advanced Malignant perivascular epithelioid cell tumors (PEComa): Preliminary efficacy, safety, and mutational status from AMPECT, an open label phase II registration trial","volume":"37","author":"Wagner","year":"2019","journal-title":"J Clin Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002505","article-title":"Malignant perivascular epithelioid cell tumor of lung on FDG PET\/CT","volume":"44","author":"Wu","year":"2019","journal-title":"Clin Nucl Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1097\/RLU.0b013e31820ae032","article-title":"Malignant perivascular epithelioid cell tumor (PEComa) of the uterus: serial imaging with F-18 FDG PET\/CT for surveillance of recurrence and evaluation of response to therapy","volume":"36","author":"Ciarallo","year":"2011","journal-title":"Clin Nucl Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.08.10","article-title":"Pulmonary metastasectomy for sarcoma-survival and prognostic analysis","volume":"11","author":"Dudek","year":"2019","journal-title":"J Thorac Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S351284","article-title":"Management strategies for adults with locally advanced, unresectavle or metastatic Malignant perivascular epithelioid cell tumor (PEComa): challenges and solutions","volume":"15","author":"Czarnecka","year":"2023","journal-title":"Cancer Manag Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"53056","DOI":"10.1155\/2007\/53056","article-title":"PEComa of the upper extremity: A unique case and description of an initial response to neoadjuvant chemotherapy","volume":"2007","author":"Osei","year":"2007","journal-title":"Sarcoma"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S1658-3876(09)50013-1","article-title":"Perivascular epithelioid cell tumor (PEComa) of the uterus with aggressive behavior at presentation","volume":"2","author":"Liu","year":"2009","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.5858\/133.4.648","article-title":"Perivascular epithelioid cell tumor","volume":"133","author":"Armah","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13014-018-0974-5","article-title":"Unresectavle hepatic PEComa: a rare Malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection","volume":"13","author":"Kirste","year":"2018","journal-title":"Radiat Oncol Lond Engl"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e945177","DOI":"10.12659\/AJCR.945177","article-title":"Adrenal PEComa treated by surgical resection and postoperative radiotherapy: A case report","volume":"25","author":"Akay","year":"2024","journal-title":"Am J Case Rep"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1045119","article-title":"Anti-PD-1 immunotherapy combined with stereotactic body radiation therapy and GM-CSF for the treatment of advanced Malignant PEComa: A case report","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-024-07578-z","article-title":"Is there any role for radiotherapy in the management of uterine perivascular epithelioid cell tumors (PEComas)","volume":"310","author":"Zagardo","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"B66","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s13256-021-02997-x","article-title":"Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report","volume":"15","author":"McBride","year":"2021","journal-title":"J Med Case Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01728","article-title":"nab-sirolimus for patients with Malignant perivascular epithelioid cell tumors","volume":"39","author":"Wagner","year":"2021","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.11516","article-title":"Long-term follow-up for duration of response (DoR) after weekly nab-sirolimus in patients with advanced Malignant perivascular epithelioid cell tumors (PEComa): Results from a registrational open-label phase II trial","year":"2020","journal-title":"J Clin Oncol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.3390\/jcm10163705","article-title":"Efficacy of sirolimus treatment in PEComa\u201310 years of practice perspective","volume":"10","author":"\u015awitaj","year":"2021","journal-title":"J Clin Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2021.100657","article-title":"Molecularly targeted radiation therapy using mTOR inhibition for the management of Malignant perivascular epithelioid cell tumor (PEComa): A case report and review","volume":"6","author":"Bajaj","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1590\/1516-3180.2017.0120050717","article-title":"Recurrence of retroperitoneal localized perivascular epithelioid cell tumor two years after initial diagnosis: case report","volume":"137","author":"Cihan","year":"2019","journal-title":"Sao Paulo Med J Rev Paul Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq044","article-title":"Treatment with the mTOR inhibitor temsirolimus in patients with Malignant PEComa","volume":"21","author":"Italiano","year":"2010","journal-title":"Ann Oncol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3390\/genes13111932","article-title":"The impact of TSC-1 and -2 mutations on response to therapy in Malignant PEComa: A multicenter retrospective analysis","volume":"13","author":"Liu","year":"2022","journal-title":"Genes"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.641376","article-title":"VEGFR inhibitors for uterine metastatic perivascular epithelioid tumors (PEComa) resistant to mTOR inhibitors. A case report and review of literature","volume":"11","author":"Liapi","year":"2021","journal-title":"Front Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.797275","article-title":"Uterine perivascular epithelioid tumors (PEComas) with lung metastasis showed good responses to mTOR and VEGFR inhibitors: A case report","volume":"12","author":"Sui","year":"2022","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1551663\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:29:01Z","timestamp":1755494941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1551663\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":75,"alternative-id":["10.3389\/fonc.2025.1551663"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1551663","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"article-number":"1551663"}}